PSA decline of 30% may be surrogate marker for overall survival: Commentary
Publication
, Other
Freedland, SJ; Moul, JW
Published in: Oncology Report
September 1, 2007
Duke Scholars
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2007
Issue
FALL
Start / End Page
52 / 53
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Freedland, S. J., & Moul, J. W. (2007). PSA decline of 30% may be surrogate marker for overall survival: Commentary. Oncology Report.
Freedland, S. J., and J. W. Moul. “PSA decline of 30% may be surrogate marker for overall survival: Commentary.” Oncology Report, September 1, 2007.
Freedland SJ, Moul JW. PSA decline of 30% may be surrogate marker for overall survival: Commentary. Oncology Report. 2007. p. 52–3.
Freedland, S. J., and J. W. Moul. “PSA decline of 30% may be surrogate marker for overall survival: Commentary.” Oncology Report, no. FALL, 1 Sept. 2007, pp. 52–53.
Freedland SJ, Moul JW. PSA decline of 30% may be surrogate marker for overall survival: Commentary. Oncology Report. 2007. p. 52–53.
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2007
Issue
FALL
Start / End Page
52 / 53
Related Subject Headings
- Oncology & Carcinogenesis